120 related articles for article (PubMed ID: 38747153)
21. Survival analysis of surgically treated renal cell carcinoma: a single Chinese medical center experience from 2002 to 2012.
Zhang Y; Yu H; Li H
Int Urol Nephrol; 2015 Aug; 47(8):1327-33. PubMed ID: 26163269
[TBL] [Abstract][Full Text] [Related]
22. Renal cell carcinoma in patients with end-stage renal disease has favorable overall prognosis.
Shrewsberry AB; Osunkoya AO; Jiang K; Westby R; Canter D; Pattaras J; Turgeon N; Master VA; Ogan K
Clin Transplant; 2014 Feb; 28(2):211-6. PubMed ID: 24494735
[TBL] [Abstract][Full Text] [Related]
23. Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease.
Takagi T; Kondo T; Omae K; Iizuka J; Kobayashi H; Yoshida K; Hashimoto Y; Tanabe K
Int Urol Nephrol; 2016 Sep; 48(9):1421-7. PubMed ID: 27193433
[TBL] [Abstract][Full Text] [Related]
24. Pathologic characterization of renal epithelial neoplasms arising in nonfunctioning kidneys.
Lin X; Goyal R; Yang XJ
Hum Pathol; 2020 Mar; 97():1-7. PubMed ID: 31857138
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
Haferkamp A; Kurosch M; Pritsch M; Hatiboglu G; Macher-Goeppinger S; Pfitzenmaier J; Pahernik S; Wagener N; Hohenfellner M
Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334
[TBL] [Abstract][Full Text] [Related]
26. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes.
Long CJ; Canter DJ; Kutikov A; Li T; Simhan J; Smaldone M; Teper E; Viterbo R; Boorjian SA; Chen DY; Greenberg RE; Uzzo RG
BJU Int; 2012 May; 109(10):1450-6. PubMed ID: 22221502
[TBL] [Abstract][Full Text] [Related]
27. Treatment trends, determinants, and survival of partial and radical nephrectomy for stage I renal cell carcinoma: results from the National Cancer Data Base, 2004-2013.
Plante K; Stewart TM; Wang D; Bratslavsky G; Formica M
Int Urol Nephrol; 2017 Aug; 49(8):1375-1381. PubMed ID: 28550475
[TBL] [Abstract][Full Text] [Related]
28. Outcome of advanced renal cell carcinoma arising in end-stage renal disease: comparison with sporadic renal cell carcinoma.
Ishihara H; Fukuda H; Tachibana H; Yoshida K; Kobayashi H; Takagi T; Iizuka J; Ishida H; Nagashima Y; Kondo T; Tanabe K
Clin Exp Nephrol; 2021 Jun; 25(6):674-682. PubMed ID: 33641007
[TBL] [Abstract][Full Text] [Related]
29. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.
Margulis V; Tamboli P; Jacobsohn KM; Swanson DA; Wood CG
BJU Int; 2007 Dec; 100(6):1235-9. PubMed ID: 17979923
[TBL] [Abstract][Full Text] [Related]
30. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
[TBL] [Abstract][Full Text] [Related]
31. Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.
O'Malley RL; Hayn MH; Brewer KA; Underwood W; Hellenthal NJ; Kim HL; Sorokin I; Schwaab T
World J Urol; 2015 Nov; 33(11):1807-14. PubMed ID: 25805189
[TBL] [Abstract][Full Text] [Related]
32. Is Robotic Partial Nephrectomy Safe for T3a Renal Cell Carcinoma? Experience of a High-Volume Center.
Andrade HS; Zargar H; Akca O; Kara O; Caputo PA; Ramirez D; Andrés G; Stein RJ; Chueh SJ; Kaouk JH
J Endourol; 2017 Feb; 31(2):153-157. PubMed ID: 27881027
[TBL] [Abstract][Full Text] [Related]
33. Functional and oncologic outcomes after nephron-sparing surgery in a solitary kidney: 10 years of experience.
Costabel JI; Marchinena PG; Tirapegui F; Dantur A; Jurado A; Gueglio G
Int Braz J Urol; 2016; 42(2):253-61. PubMed ID: 27256179
[TBL] [Abstract][Full Text] [Related]
34. Increased risk of end-stage renal disease in patients with renal cell carcinoma: a 12-year nationwide follow-up study.
Hung PH; Tsai HB; Hung KY; Muo CH; Chung MC; Chang CH; Chung CJ
Medicine (Baltimore); 2014 Aug; 93(8):e52. PubMed ID: 25121356
[TBL] [Abstract][Full Text] [Related]
35. A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma.
Morgan TM; Mehra R; Tiemeny P; Wolf JS; Wu S; Sangale Z; Brawer M; Stone S; Wu CL; Feldman AS
Eur Urol; 2018 May; 73(5):763-769. PubMed ID: 29249291
[TBL] [Abstract][Full Text] [Related]
36. Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery.
Butler BP; Novick AC; Miller DP; Campbell SA; Licht MR
Urology; 1995 Jan; 45(1):34-40; discussion 40-1. PubMed ID: 7817478
[TBL] [Abstract][Full Text] [Related]
37. Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma ≤7 cm T3aN0/xM0: Survival benefit is biased toward partial nephrectomy.
Liu S; Feng C; Liu C; Wang Z
Cancer Med; 2021 Dec; 10(24):8909-8923. PubMed ID: 34779154
[TBL] [Abstract][Full Text] [Related]
38. Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (≤4 cm): an analysis of the SEER database.
Daugherty M; Bratslavsky G
Urol Oncol; 2014 Jul; 32(5):549-54. PubMed ID: 24495447
[TBL] [Abstract][Full Text] [Related]
39. Renal Functional Outcomes after Surgery, Ablation, and Active Surveillance of Localized Renal Tumors: A Systematic Review and Meta-Analysis.
Patel HD; Pierorazio PM; Johnson MH; Sharma R; Iyoha E; Allaf ME; Bass EB; Sozio SM
Clin J Am Soc Nephrol; 2017 Jul; 12(7):1057-1069. PubMed ID: 28483780
[TBL] [Abstract][Full Text] [Related]
40. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
Leibovich BC; Blute M; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
